Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

BUPIVACAINE HYDROCHLORIDE INJECTION, USP 7.5 MG

BUPIVACAINE HYDROCHLORIDE : 7.5 MG · DIN 02488930 · BAXTER CORPORATION

Health Canada status: MARKETED

What is BUPIVACAINE HYDROCHLORIDE INJECTION, USP?

BUPIVACAINE HYDROCHLORIDE INJECTION, USP 7.5 MG contains BUPIVACAINE HYDROCHLORIDE : 7.5 MG. It is listed in the Health Canada Drug Product Database under DIN 02488930, held by BAXTER CORPORATION, supplied as SOLUTION for RETROBULBAR ; EPIDURAL administration. Health Canada currently lists it as marketed, status dated 15-Aug-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02488930
Brand nameBUPIVACAINE HYDROCHLORIDE INJECTION, USP
Generic / active ingredientBUPIVACAINE HYDROCHLORIDE : 7.5 MG
ManufacturerBAXTER CORPORATION
Strength7.5 MG
Dosage formSOLUTION
Route of administrationRETROBULBAR ; EPIDURAL
ScheduleEthical
ATC codeN01BB01 BUPIVACAINE
AHFS class24:32.04
BiosimilarNo
Health Canada statusMARKETED
Status date15-Aug-2022
Original market date2019-07-09 00:00:00

Is BUPIVACAINE in shortage in Canada?

A Canadian shortage report is on file for this molecule: Active — reported by OMEGA LABORATORIES LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for BUPIVACAINE HYDROCHLORIDE INJECTION, USP

What can be used instead?

Other Canadian products sharing ATC code N01BB01 BUPIVACAINE. 10 of 42 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP7.5 MGSOLUTIONFORMATIVE PHARMA INC.MARKETEDDIN 02536714
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP7.5 MGSOLUTIONOMEGA LABORATORIES LIMITEDMARKETEDDIN 02512424
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP7.5 MGSOLUTIONSTERIMAX INCMARKETEDDIN 02460645
BUPIVACAINE INJECTION BP2.5 MGSOLUTIONSTERIMAX INCMARKETEDDIN 02443686
BUPIVACAINE INJECTION BP5 MGSOLUTIONSTERIMAX INCMARKETEDDIN 02443694
MARCAINE150 MG / 20 MLSOLUTIONPFIZER CANADA ULCMARKETEDDIN 02241917
MARCAINE250 MG / 50 MLSOLUTIONPFIZER CANADA ULCMARKETEDDIN 02305909
SENSORCAINE2.5 MGSOLUTIONASPEN PHARMACARE CANADA INC.MARKETEDDIN 01976141
SENSORCAINE5 MGSOLUTIONASPEN PHARMACARE CANADA INC.MARKETEDDIN 01976168
BUPIVACAINE HEAVY INJECTION BP15 MG / 2 MLSOLUTIONAURO PHARMA INCAPPROVEDDIN 02470616

Who else supplies BUPIVACAINE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. BUPIVACAINE appears in 19 registered pack listings across 5 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for BUPIVACAINE HYDROCHLORIDE INJECTION, USP

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for BUPIVACAINE HYDROCHLORIDE INJECTION, USP

Health Canada Drug Product Database (DPD), DIN 02488930. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.